The accumulation of a drug in the human body during a constant-rate intravenous infusion was first treated mathematically by Widmark and Tandberg," based on the one-compartment open model. Based on this analysis, the loading dose (units of mass) needed to rapidly attain the steady state is equal to the infusion rate
(units of mass/time) divided by the elimination rate constant (units of l/time). The elimination rate constant is equal to the natural logarithm of 2 (namely, 0.693) divided by the half-life of the drug. The theory, based on this one-compartment analysis, indicates that if one administers this loading dose by rapid intravenous injection and, at the same time, starts a constant-rate infusion, a steady state will be "instantaneously" established and the plasma concentration of drug would be the same from time zero to the time the infusion ceases. It is desirable to rapidly attain steady state in many pharmacokinetic studies, such as renal clearance studies, as well as in the therapy of certain diseases where the site action of the drug is in the central (plasma) compartment. Using the preceding conditions, many clinicians appear to be unaware that the initial plasma concentration at time zero (just after injection of the loading dose) can be very much higher than the final steady-state plasma concentration, since, frequently, the first blood sample is not taken until an hour or more after injection of the loading dose and the start of the intravenous infusion, while the drug obeys the two-compartment rather than the one-compartment open model.
Most drugs really do not obey the onecompartment model, but rather the twocompartment open model, depicted in Schema 1. In this model k12 and k21 are firstorder distribution rate constants and kel is the first-order elimination rate constant. The plasma concentration is taken as representative of the concentration, Cl , in compartment No. 1 (also called the "central" compartment) at time t after administration. When a drug obeys this model the apparent elimination rate constant, /3, obtained from terminal plasma concentration data, is a complex function of kl2, k21' and k el ; the half-life of elimination, obtained from plasma concentration data, is t\2 = 0.693//3.
Clinical Pharmacology and Therapeutics
During the past decade the parameters k 12 , k2h keh and VI of the model shown in Schema I have been published for many drugs. This report shows how a given set of parameters for a given subject or animal and for a given drug may be used to calculate two successive infusion rates that provide rapid attainment of steady-state plasma levels and the maximum plasma concentration attained at the end of the initial infusion at the faster rate. Although most useful for pharmacokinetic studies, the method may find some application in therapy of certain diseases also.
Experimental and results
Conceptual infusion at one rate only. If a constant-rate infusion is given without a loading dose it takes a long time to approach steady state. This is indicated by Fig. 1 , which shows the time-course for the first 10 hours for theophylline, based on the average values of the parameters of 3 subjects published by Mitenko and Ogilvie. 3 The simulation is based on a steady-state plasma concentration of 10 p.g/ml. In this case it would require 18.77 hours (equivalent to 4.26 half-life periods of theophylline) to reach 95% of the steady-state value (i.e., 9.5p.g/ml) and 9.94 hours (equivalent to 2.25 half-life periods) to reach 80% of the steady-state value (i.e., 8.0p.g/ml). For drugs with half-lives that are greater than about 0.5 hr., the Single-infusion method is not very practical.
Infusion plus loading dose. For the model shown in Schema I, the relative values of the loading dose (R) and the infusion rate (Q) are critical in determining the time-course of plasma concentrations. Boyes and associates l recommended that the relationship should be R = Q/k el . Mitenko and Ogilvie 4 recommended that the relationship should be R = Q//3. The simulations shown in Fig. 2 are typical of the. results that would be achieved with theophylline with these recommendations. When R = Q/kel then at t = 0, C~ = 10 p.g/ml, but the plasma concentration then drops, reaches a minimum, then slowly rises and approaches the equilibrium concentration of 10 Itg/ml again. When R = Q//3, then at t = 0, C~ = 29.4 /tg/ml and the plasma concentration drops rapidly and within about 1 hour is essentially equal to the steady-state concentration of 10 /tg/ml. The ratio of the initial concentration (G) to the equilibrium concentration (C';'l) is equal to k,,[//3. The inverse ratio, /3/k.J, indicates how "two compartment" a particular drug is. The smaller this ratio the greater the amount of drug in compartment No. 2 compared with the amount in compartment No. 1 at any time (Schema I). The influence of this ratio on the ratio of C~ I' C"? is shown in Fig. 3 . Kruger-Thiemer,z recommended administering the loading dose, then a continuous infusion, the rate of which decreases exponentially to the proper steady-state rate, but this is more difficult than the new method proposed.
Two consecutive infusions.
A new method is described below in which an initial constant-rate infusion is given at a rate Ql over T hours. At the end of T hours the infusion rate is abruptly changed to a lower rate Q" which is maintained as long as a steady-state plasma concentration is desired.
A critical ratio of Ql/Q" has been determined (Equation 8, Appendix), which provides the most rapid attainment of the steady state. The steps required to apply the method are indicated below (see also Table I): 1. Choose the equilibrium state plasma level desired (i.e., choose C'~I).
2. Calculate the final infusion rate as follows:
3. Choose the time T over which to administer the initial infusion at the rate Ql' This often can be 0.25 hr (15 min), but with some toxic drugs should be as long as 3 or 4 hours. Fig. 6 and Equation 18 aid in the choice of T. 4. Calculate the ratio of the half-life of the drug (ty,) to the chosen time T (i.e., ty,/T) .
5. Use the graph in Fig. 4 for this value of ty,/T to nnd the ratio Ql/QZ' 6. Since you know Q2 you can now cal-
The above procedure is accurate as long at ty,/T is equal to or greater than 6.93. Whenever the ratio ty,/T is less than 6.93 then Ql should be calculated by means of Equation 7 (Appendix). Fig. 5 illustrates the results to be achieved with this method with theophylline and a comparison is made of the results that would be obtained by the method of Mitenko and Ogilvie. 4 For this simulation the average parameter values of theophylline, given by Mitenko and Ogilvie/ for 7 asthmatic patients were used. These values were a = 5.99 hr\ f3 = 0.162 hrl, k.! = 0.312 hr-\ and VI = 0.277 l/kg. From these one can calculate k12 = 2.73 hri and kZl = 3.11 hri. The simulation is based on choosing C"~l = 10 ,ug/ml and T = 0.5 hr. The steps for this example, corresponding to steps 1 to 6 above, are as follows:
1. C'~l = 10 ,ug/ml. Table I. method 3 are very similar to real plasma concentration, time curves of theophylline published by these authors, except here Cel Q = 10 fLg/ml, whereas in their article Ce~ = 5 fL g/ml.
Discussion
If we let C~AX be the maximum plasma concentration at time T just when the infusion rates are changed in the proposed method (peak in Fig. 5 at 0.5 hr), then in this simulation cMt X = 12.9 fLg/ml, corresponding to C~ = 19.3 fLg/ml with the Ogilvie-Mitenko method. However, if T had been made longer (lor 2 hr) then CM~X would have been much smaller. This is the advantage of the proposed method. One can set the ratio of CM~X /C~Q to any desired value by adjusting the time T of the initial infusion. Once the final infusion is started, the time required to reach the steady-state plasma concentration is based '" only on the value of e-<>t as in the MitenkoOgilvie' method. Since 0' is usually quite large, then e-<>t approaches zero rapidly and the fall from CM~X to C'~l is rapid, as ranges from about 1.6 to 5. Hence C~/C'~l ranges from 1.6 to 5. Such high initial plasma concentrations can lead to toxicity, particularly with drugs with a narrow range between the toxic and therapeutic doses and plasma levels. I suggest that the proposed consecutive infusion method is a much safer procedure. Harvard infusion pumps have different settings and with this type of pump it is easy to give an initial infusion at one rate and abruptly change to a lower rate simply by dialing to a new setting. If a drop apparatus is used, one could determine the drop rate to provide the two rates Ql and Q2 and predetermine the clamp settings needed to provide the two drop rates. 
where (2) and a and f3 are defined by Wagner 5 and many other authors. Two consecutive infusions. In this method an initial infusion is given at the rate Q, over T hours (Le., in the interval 0 ~ t ~ T). At time T the infusion rate is abruptly changed to the lower rate Q, = V,keJCe~ (i.e., for t ~ T).
The concentration during the interval 0 ~ t ~ T will be given by Equations 1 and 2 where Q, replaces Q in Equation 2.
The concentration during the second infusion will be given by Equations 3, 4, and 5, where
For C , to be always greater than or equal to C 
Hence the concentration C, during the second infusion will always be greater than or equal to ce 1 Q . when the ratio of the infusion rates is given by (8) If a single bolus intravenous injection of a drug is administered, then the plasma concentration, time curve can usually be fitted to Equation 9, 6. If such a drug has a long half-life (small value of /3) the value of al/3 will usually in Fig. 6 . If such a drug has a long half-life (small value of /3) the value of al/3 will usually be large, which together with the low value of b;,/T will provide a reasonably low ratio of CM~x/Ce~.
